Alvotech Management
Management criteria checks 3/4
Alvotech's CEO is Lisa Graver, appointed in Mar 2026, has a tenure of less than a year. directly owns 0.007% of the company’s shares, worth $76.60K. The average tenure of the management team and the board of directors is 1.1 years and 5.5 years respectively.
Key information
Lisa Graver
Chief executive officer
US$186.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.007% |
| Management average tenure | 1.1yrs |
| Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Alvotech: Improving Fundamentals Signal A Potential Bottom For This Biosimilar Player
Apr 10Statutory Earnings May Not Be The Best Way To Understand Alvotech's (NASDAQ:ALVO) True Position
Nov 20
Alvotech's (NASDAQ:ALVO) 31% Dip In Price Shows Sentiment Is Matching Revenues
Nov 09Analysts Just Slashed Their Alvotech (NASDAQ:ALVO) EPS Numbers
Nov 06Alvotech (NASDAQ:ALVO) Held Back By Insufficient Growth Even After Shares Climb 29%
May 25Alvotech's (NASDAQ:ALVO) Promising Earnings May Rest On Soft Foundations
May 15
Biosimilar Pipeline And R&D Capability Will Open New Markets
Upcoming biosimilar launches and strategic manufacturing expansions might drive substantial revenue and margin growth, leveraging lost biologic patents.Benign Growth For Alvotech (NASDAQ:ALVO) Underpins Stock's 25% Plummet
Apr 08Alvotech's Position In The Coming Biosimilar Gold Rush
Nov 21Alvotech: Steady Progress Offers A Good Chance Of Upside
Aug 26Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts
May 28Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
Apr 25Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24CEO
Lisa Graver (53 yo)
Ms. Lisa Graver served as Chief Executive Officer of Alvogen, Inc. until December 2025. She was a Non-Executive Director of Alvotech from June 16, 2022 until March 31, 2025 and serves as its Chief Executiv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 7.3yrs | US$2.89m | no data | |
| Chief Executive Officer | less than a year | US$186.00k | 0.0068% $ 76.6k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Operating Officer | 1.3yrs | no data | 0.049% $ 557.6k | |
| Vice President of Investor Relations & Global Communications | no data | no data | no data | |
| General Counsel | 3.3yrs | no data | 0% $ 0 | |
| Head of Global Communications | no data | no data | no data | |
| Senior Vice President of Global Talent & People Experience | 1.3yrs | no data | no data | |
| Chief Quality & Regulatory Officer | 2.3yrs | no data | no data | |
| Chief Strategy Officer | 1.1yrs | no data | no data | |
| Vice President & Head of Business Development | less than a year | no data | no data | |
| Senior Vice President of Global Business Development and Commercial Operation | less than a year | no data | no data |
Experienced Management: ALVO's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 7.3yrs | US$2.89m | no data | |
| Director | 1.8yrs | US$149.00k | 0.00075% $ 8.5k | |
| Non-Executive Director | 7.3yrs | no data | no data | |
| Non-Executive Director | 3.8yrs | no data | no data | |
| Independent Non-Executive Deputy Chairman | 7.3yrs | US$307.00k | 0.35% $ 3.9m | |
| Independent Non-Executive Director | 3.8yrs | US$241.00k | 0.0068% $ 76.6k |
Experienced Board: ALVO's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/12 18:39 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Alvotech is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Glen Santangelo | Barclays |
| Andrew Baum | Citigroup Inc |
| Peter Verdult | Citigroup Inc |